Inventor · disambiguated record
Kenneth Albert Brameld
Also filed as: BRAMELD KENNETH · BRAMELD KENNETH A · BRAMELD KENNETH ALBERT
27 granted patents·6 pending applications·164 citations·filing 2007–2023
96Inventor score
Files withPRINCIPIA BIOPHARMA INC18ROIVANT SCIENCES GMBH4KAROS PHARMACEUTICALS INC3HOFFMANN LA ROCHE2ALTAVANT SCIENCES GMBH1
Top patents by PatentIndex Score
33 records- 0197US8957080B2Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Feb 17, 2015·19 cites·24 claims
- 0296US11827656B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2021·Granted Nov 28, 2023·2 cites·27 claims
- 0396US10946018B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2020·Granted Mar 16, 2021·6 cites·18 claims
- 0496US9199994B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2014·Granted Dec 1, 2015·31 cites·48 claims
- 0594US10660893B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2019·Granted May 26, 2020·6 cites·18 claims
- 0694US10045988B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2017·Granted Aug 14, 2018·11 cites·26 claims
- 0794US9750740B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·14 cites·26 claims
- 0893US11225493B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2018·Granted Jan 18, 2022·4 cites·32 claims
- 0993US9512122B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·15 cites·100 claims
- 1092US10350208B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2018·Granted Jul 16, 2019·7 cites·36 claims
- 1190US9567334B2Quinolone derivatives as fibroblast growth factor receptor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2016·Granted Feb 14, 2017·6 cites·16 claims
- 1289US11759462B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Sep 19, 2023·1 cites·24 claims
- 1389US11078199B2Quinolone derivatives as fibroblast growth factor receptor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2019·Granted Aug 3, 2021·2 cites·15 claims
- 1488US9376438B2Pyrazolopyrimidine derivatives as tyrosine kinase inhibitorsGOLDSTEIN DAVID MICHAEL·Filed 2012·Granted Jun 28, 2016·14 cites·20 claims
- 1587US12162882B2Quinolone derivatives as fibroblast growth factor receptor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2023·Granted Dec 10, 2024·0 cites·11 claims
- 1687US9815834B2Quinolone derivatives as fibroblast growth factor receptor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2015·Granted Nov 14, 2017·4 cites·16 claims
- 1785US11154563B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2018·Granted Oct 26, 2021·2 cites·28 claims
- 1884US10538517B2Quinolone derivatives as FGFR inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2016·Granted Jan 21, 2020·3 cites·23 claims
- 1983US10294223B2Quinolone derivatives as fibroblast growth factor receptor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2017·Granted May 21, 2019·2 cites·15 claims
- 2082US8273773B2Heterocyclic antiviral compoundsBRAMELD KENNETH ALBERT·Filed 2009·Granted Sep 25, 2012·11 cites·33 claims
- 2178US12312370B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 2277US9630963B2Quinolone derivatives as fibroblast growth factor inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2014·Granted Apr 25, 2017·3 cites·14 claims
- 2375US2021292323A1Quinolone Derivatives as Fibroblast Growth Factor InhibitorsPRINCIPIA BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2468US9676778B2Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Jun 13, 2017·1 cites·24 claims
- 2549US2007287699A1Antiviral agentsVIROBAY INC·Filed 2007·Application pending·0 cites
- 2645US12024531B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2018·Granted Jul 2, 2024·0 cites·21 claims
- 2743US9573958B2Benzimidazole derivatives as ITK inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Feb 21, 2017·0 cites·31 claims
- 2843US2014107151A1Tyrosine kinase inhibitorsPRINCIPAL BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 2942US2015353557A1Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 3038US2013090334A1Azabenzoxazine derivatives as crac modulatorsHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 3136US2013090333A1Benzoxazine derivatives as crac modulatorsHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 3235US10654843B2LMP7 inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2015·Granted May 19, 2020·0 cites·3 claims
- 3335US9187487B2Azaindole derivatives as tyrosine kinase inhibitorsGOLDSTEIN DAVID M·Filed 2012·Granted Nov 17, 2015·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →